髙知大学医学部 老年病?循環器内科学

MENU

業績

業績

英文論文

2024年

  1. Associations between electrocardiographic findings and echocardiographic profiles in patients with hypertrophic cardiomyopathy.
    • Matsuo T, Ochi Y, Kubo T, Baba Y, Miyagawa K, Noguchi T, Hirota T, Hamada T, Yamasaki N, Kitaoka H.
    • J Cardiol 83; 359-364, 2024.
  2. alpha-L-iduronidase fused with humanized anti-human transferrin receptor antibody (lepunafusp alfa) for mucopolysaccharidosis type I: A phase 1/2 trial.
    • Harmatz P, Giugliani R, Martins AM, Hamazaki T, Kubo T, Kira R, Minami K, Ikeda T, Moriuchi H, Kawashima S, Takasao N, So S, Sonoda H, Hirato T, Tanizawa K, Schmidt M, Sato Y.
    • Mol Ther 32; 609-618, 2024.
  3. Demographic Determinants Influencing the Adoption of Genetic Testing for Cardiovascular Diseases in Japan - Insights From a Large-Scale Online Survey.
    • Isa K, Suzuki T, Nomura S, Miyoshi T, Fujita K, Kubo T, Yoneoka D, Mizuno A
    • Circ Rep 6; 178-182, 2024
  4. Prognostic impact of frailty based on a comprehensive frailty assessment in patients with heart failure.
    • Hamada T, Kubo T, Kawai K, Nakaoka Y, Yabe T, Furuno T, Yamada E, Kitaoka H; Kochi YOSACOI study.
    • ESC Heart Fail. 2024 Mar 28.doi: 10.1002/ehf2.14728. 
  5. Clinical features of quadricuspid aortic valve in middle-aged and elderly patients: Insights from a regional study.
    • Takiishi A, Baba Y, Ochi Y, Hotta M, Okazaki N, Yoshinaga Y, Miyamoto S, Hirakawa D, Kawaguchi J, Kubo T, Yamasaki N, Tokuhiro S, Kitaoka H.
    • Echocardiography. 2024 Apr;41(4):e15817. doi: 10.1111/echo.15817.
  6. Relationship of Mild to Moderate Impairment of Left Ventricular Ejection Fraction With Fatal Ventricular Arrhythmic Events in Cardiac Sarcoidosis.
    • Akama Y, Fujimoto Y, Matsue Y, Maeda D, Yoshioka K, Dotare T, Sunayama T, Nabeta T, Naruse Y, Kitai T, Taniguchi T, Sato S, Tanaka H, Okumura T, Baba Y, Minamino T.
    • J Am Heart Assoc. 2024 Mar 19;13(6):e032047. doi: 10.1161/JAHA.123.032047. Epub 2024 Mar 8.
  7. Clinical characteristics and prognosis of patients with isolated cardiac sarcoidosis: Insights from the ILLUMINATE-CS study.
    • Maeda D, Matsue Y, Dotare T, Sunayama T, Iso T, Yoshioka K, Nabeta T, Naruse Y, Kitai T, Taniguchi T, Tanaka H, Okumura T, Baba Y, Minamino T.
    • Eur J Heart Fail. 2024 Jan;26(1):77-86. doi: 10.1002/ejhf.3056. Epub 2023 Nov 3.

2023年

  1. Frailty interferes with the guideline-directed medical therapy in heart failure patients with reduced ejection fraction.
    • Hamada T, Kubo T, Kawai K, Nakaoka Y, Yabe T, Furuno T, Yamada E, Kitaoka H; Kochi YOSACOI study.
    • ESC Heart Fail 10; 223-233, 2023.
  2. Current state of knowledge and information sharing among home healthcare professionals involved in heart failure management.
    • Shimomoto R, Kubo T, Yamanaka F, Tsuchihashi-Makaya M, Suganuma N, Kitaoka H.
    • J Cardiol 81; 292-296, 2023.
  3. Estimating the prevalence, clinical characteristics, and treatment patterns of hypertrophic cardiomyopathy in Japan: A nationwide medical claims database study.
    • Terasaka N, Spanopoulos D, Miyagoshi H, Kubo T, Kitaoka H.
    • J Cardiol 81; 316-322, 2023.
  4. External Validation of the Japanese Clinical Score for Mortality Prediction in Patients With Acute Heart Failure.
    • Takabayashi K, Hamada T, Kubo T, Iwatsu K, Ikeda T, Okada Y, Kitamura T, Kitaguchi S, Kimura T, Kitaoka H, Nohara R.
    • Circ J 87; 543-550, 2023.
  5. High-sensitivity Cardiac Troponin T is a Useful Biomarker for Predicting the Prognosis of Patients with Systemic Sarcoidosis Regardless of Cardiac Involvement.
    • Baba Y, Kubo T, Ochi Y, Hirota T, Yamasaki N, Ohnishi H, Kubota T, Yokoyama A, Kitaoka H.
    • Intern Med 62; 3097-3105, 2023.
  6. JCS 2023 Guideline on the Diagnosis and Treatment of Myocarditis.
    • Nagai T, Inomata T, Kohno T, Sato T, Tada A, Kubo T, Nakamura K, Oyama-Manabe N, Ikeda Y, Fujino T, Asaumi Y, Okumura T, Yano T, Tajiri K, Matsuura H, Baba Y, Sunami H, Tsujinaga S, Ota Y, Ohta-Ogo K, Ishikawa Y, Matama H, Nagano N, Sato K, Yasuda K, Sakata Y, Kuwahara K, Minamino T, Ono M, Anzai T; Japanese Circulation Society Joint Working Group.
    • Circ J 87; 674-754, 2023.
  7. Genetic Testing for Cardiomyopathy in Japan 2022: Current Status and Issues of Precision Medicine.
    • Kubo T, Kitaoka H
    • J Card Fail 29: 805-814, 2023.(IF 6.7)
  8. Transient decrease in the depth of the negative T wave in apical hypertrophic cardiomyopathy is a sign of left anterior descending artery stenosis: a case series.
    • Arima N, Ochi Y, Takahashi M, Moriki T, Noguchi T, Kubo T, Yamasaki N, Kitaoka H.
    • Eur Heart J Case Rep 7(1):ytad034, 2023.
  9. Mitral Valve Repair with Papillary Muscle Repositioning for Functional Mitral Regurgitation (Type IIIb) with Metal Allergies: A Case Report. European Heart Journal - Case Reports.
    • Mitsuishi A, Miura Y, Kubo T.
    • Eur Heart J Case Rep 7; ytad283, 2023.
  10. Characteristics and incidence of cardiac events across spectrum of age in cardiac sarcoidosis.
    • Nabeta T, Matsumoto S, Ishii S, Eda Y, Yazaki M, Fujita T, Iida Y, Ikeda Y, Kitai T, Naruse Y, Taniguchi T, Yoshioka K, Tanaka H, Okumura T, Baba Y, Matsue Y, Ako J.
    • Int J Cardiol Heart Vasc. 2023 Dec 8;50:101321. doi: 10.1016/j.ijcha.2023.101321. eCollection 2024 Feb.
  11. Prevalence and prognostic value of atrial fibrillation in patients with cardiac sarcoidosis.
    • Fujimoto Y, Matsue Y, Maeda D, Dotare T, Sunayama T, Iso T, Nakamura Y, Singh YS, Akama Y, Yoshioka K, Kitai T, Naruse Y, Taniguchi T, Tanaka H, Okumura T, Baba Y, Nabeta T, Minamino T.
    • Eur Heart J Open. 2023 Sep 27;3(5):oead100. doi: 10.1093/ehjopen/oead100. eCollection 2023 Sep.
  12. The role of ferroptosis in cell-to-cell propagation of cell death initiated from focal injury in cardiomyocytes.
    • Kawasaki NK, Suhara T, Komai K, Shimada BK, Yorichika N, Kobayashi M, Baba Y, Higa JK, Matsui T.
    • Life Sci. 2023 Nov 1;332:122113. doi: 10.1016/j.lfs.2023.122113. Epub 2023 Sep 20.
  13. Prognostic Implication of the Resolution of Myocardial FDG Uptake in Patients With Cardiac Sarcoidosis.
    • Okabe T, Nabeta T, Naruse Y, Taniguchi T, Kitai T, Yoshioka K, Tanaka H, Okumura T, Baba Y, Matsue Y.
    • JACC Asia. 2023 Jun 27;3(4):683-685. doi: 10.1016/j.jacasi.2023.04.007. eCollection 2023 Aug.
  14. Sex differences in clinical characteristics and prognosis of patients with cardiac sarcoidosis.
    • Iso T, Maeda D, Matsue Y, Dotare T, Sunayama T, Yoshioka K, Nabeta T, Naruse Y, Kitai T, Taniguchi T, Tanaka H, Okumura T, Baba Y, Minamino T.
    • Heart. 2023 Aug 24;109(18):1387-1393. doi: 10.1136/heartjnl-2022-322243.
  15. JCS 2023 Guideline on the Diagnosis and Treatment of Myocarditis.
    • Nagai T, Inomata T, Kohno T, Sato T, Tada A, Kubo T, Nakamura K, Oyama-Manabe N, Ikeda Y, Fujino T, Asaumi Y, Okumura T, Yano T, Tajiri K, Matsuura H, Baba Y, Sunami H, Tsujinaga S, Ota Y, Ohta-Ogo K, Ishikawa Y, Matama H, Nagano N, Sato K, Yasuda K, Sakata Y, Kuwahara K, Minamino T, Ono M, Anzai T; Japanese Circulation Society Joint Working Group.
    • Circ J. 2023 Apr 25;87(5):674-754. doi: 10.1253/circj.CJ-22-0696. Epub 2023 Mar 31.

2022年

  1. External Validation of the Japanese Clinical Score for Mortality Prediction in Patients With Acute Heart Failure.
    • Takabayashi K, Hamada T, Kubo T, Iwatsu K, Ikeda T, Okada Y, Kitamura T, Kitaguchi S, Kimura T, Kitaoka H, Nohara R.
    • Circ J. 2022 Dec 28. doi: 10.1253/circj.CJ-22-0652.
  2. The Prognostic Value of B-Type Natriuretic Peptide in Patients With Cardiac Sarcoidosis Without Heart Failure: Insights From ILLUMINATE-CS.
    • Miyakuni S, Maeda D, Matsue Y, Yoshioka K, Dotare T, Sunayama T, Nabeta T, Naruse Y, Kitai T, Taniguchi T, Tanaka H, Okumura T, Baba Y, Matsumura A, Minamino T.
    • J Am Heart Assoc. 2022 Dec 20;11(24):e025803.
  3. Comparisons between biopsy-proven versus clinically diagnosed cardiac sarcoidosis.
    • Kitai T, Nabeta T, Naruse Y, Taniguchi T, Yoshioka K, Miyakoshi C, Kurashima S, Miyoshi Y, Tanaka H, Okumura T, Baba Y, Furukawa Y, Matsue Y, Izumi C.
    • Heart. 2022 Nov 10;108(23):1887-1894.
  4. Clinical Management and Outcomes of Patients With Portopulmonary Hypertension Enrolled in the Japanese Multicenter Registry.
    • Tamura Y, Tamura Y, Taniguchi Y, Tsujino I, Inami T, Matsubara H, Shigeta A, Sugiyama Y, Adachi S, Abe K, Baba Y, Hatano M, Ikeda S, Kusunose K, Sugimura K, Usui S, Takeishi Y, Dohi K, Hasegawa-Tamba S, Horimoto K, Kikuchi N, Kumamaru H, Tatsumi K; Japan Pulmonary Hypertension Registry Network.
    • Circ Rep. 2022 Oct 8;4(11):542-549.
  5. Risk stratification of patients with cardiac sarcoidosis: the ILLUMINATE-CS registry.
    • Nabeta T, Kitai T, Naruse Y, Taniguchi T, Yoshioka K, Tanaka H, Okumura T, Sato S, Baba Y, Kida K, Tamaki Y, Matsumoto S, Matsue Y.
    • Eur Heart J. 2022 Sep 21;43(36):3450-3459.
  6. Acute Left Circumflex Coronary Artery Occlusion - Diagnostic Problems of Initial
    • Komatsu J, Nishimura YK, Sugane H, Hosoda H, Imai RI, Nakaoka Y, Nishida K, Seki SI, Kubo T, Yamasaki N, Kitaoka H, Kubokawa SI, Kawai K, Hamashige N, Doi Y.
    • Electrocardiographic Changes. Circ Rep 4; 482-489, 2022.
  7. Incidence and Clinical Characteristics of Takotsubo Syndrome in Patients with Subarachnoid Hemorrhage.
    • Fujita T, Nakaoka Y, Hayashi S, Imai RI, Nishida K, Seki SI, Kubo T, Yamasaki N, Kitaoka H, Kubokawa SI, Kawai K, Hamashige N, Doi Y.
    • Int Heart J 63; 517-523, 2022.
  8. The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy.
    • Norrish G, Topriceanu C, Qu C, Field E, Walsh H, Zió?kowska L, Olivotto I, Passantino S, Favilli S, Anastasakis A, Vlagkouli V, Weintraub R, King I, Biagini E, Ragni L, Prendiville T, Duignan S, McLeod K, Ilina M, Fernández A, Bökenkamp R, Baban A, Drago F, Kubuš P, Daubeney PEF, Chivers S, Sarquella-Brugada G, Cesar S, Marrone C, Medrano C, Alvarez Garcia-Roves R, Uzun O, Gran F, Castro FJ, Gimeno JR, Barriales-Villa R, Rueda F, Adwani S, Searle J, Bharucha T, Siles A, Usano A, Rasmussen TB, Jones CB, Kubo T, Mogensen J, Reinhardt Z, Cervi E, Elliott PM, Omar RZ, Kaski JP.
    • Eur J Prev Cardiol 29; 645-653, 2022.
  9. Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator.
    • Protonotarios A, Bariani R, Cappelletto C, Pavlou M, García-García A, Cipriani A, Protonotarios I, Rivas A, Wittenberg R, Graziosi M, Xylouri Z, Larrañaga-Moreira JM, de Luca A, Celeghin R, Pilichou K, Bakalakos A, Lopes LR, Savvatis K, Stolfo D, Dal Ferro M, Merlo M, Basso C, Freire JL, Rodriguez-Palomares JF, Kubo T, Ripoll-Vera T, Barriales-Villa R, Antoniades L, Mogensen J, Garcia-Pavia P, Wahbi K, Biagini E, Anastasakis A, Tsatsopoulou A, Zorio E, Gimeno JR, Garcia-Pinilla JM, Syrris P, Sinagra G, Bauce B, Elliott PM.
    • Eur Heart J 43; 3053-3067, 2022.
  10. Assisted living and medication adherence in super-aged patients with heart failure in the Japanese population.
    • Kawada K, Kubo T, Ishida T, Jobu K, Morisawa S, Hamada T, Baba Y, Kawai K, Nakaoka Y, Yabe T, Furuno T, Yamada E, Fukuda H, Ohta T, Hayashi T, Kitaoka H, Miyamura M.
    • J Cardiovasc Pharmacol 79; 467-471, 2022.
  11. A Drifting Dislodged Leadless Pacemaker in the Bilateral Pulmonary Arteries.
    • Sugiura K, Baba Y, Hirota T, Kubo T, Kitaoka H.
    • JACC Case Rep 4: 844-846, 2022.
  12. Very long-term prognosis in patients with hypertrophic cardiomyopathy: a longitudinal study with a period of 20 years.
    • Sugiura K, Kubo T, Ochi Y, Miyagawa K, Baba Y, Noguchi T, Hirota T, Yamasaki N, Doi YL,Kitaoka H.
    • ESC Heart Fail 9; 2618-2625, 2022.
  13. Clinical Features of Heart Failure in Patients With Hypertrophic Cardiomyopathy in a Regional Japanese Cohort - Results From the Kochi RYOMA Study.
    • Miyamoto Y, Kubo T, Ochi Y, Baba Y, Hirota T, Yamasaki N, Kawai K, Yamamoto K, Kondo F, Bando K, Yamada E, Furuno T, Yabe T, Doi YL, Kitaoka H.
    • Circ J 86; 1939-1940, 2022.
  14. Early Experience of Tafamidis Treatment in Japanese Patients With Wild-Type Transthyretin Cardiac Amyloidosis From the Kochi Amyloidosis Cohort.
    • Ochi Y, Kubo T, Baba Y, Sugiura K, Miyagawa K, Noguchi T, Hirota T, Hamada T, Yamasaki N, Kitaoka H.
    • Circ J 86; 1121-1128, 2022.
  15. Clinical characteristics and frailty status in heart failure with preserved vs. reduced ejection fraction.
    • Hamada T, Kubo T, Kawai K, Nakaoka Y, Yabe T, Furuno T, Yamada E, Kitaoka H; Kochi YOSACOI study.
    • ESC Heart Fail 9; 1853-1863, 2022.
  16. A retrospective investigation to establish new screening approach for the detection of patients at high risk of Fabry disease in male left ventricular hypertrophy patients.
    • Kubo T, Amano M, Takashio S, Okumura T, Yamamoto S, Nabeta T, Oikawa M, Kurisu S, Ochi Y, Sugiura K, Baba Y, Kuroiwa H, Hirota T, Yamasaki N, Ishii S, Nochioka K, Takeishi Y, Yasuda S, Tsujita K, Izumi C, Kitaoka H.
    • J Cardiol 80; 325-331, 2022.
  17. Relationship Between Maximal Left Ventricular Wall Thickness and Sudden Cardiac Death in Childhood Onset Hypertrophic Cardiomyopathy.
    • Norrish G, Ding T, Field E, Cervi E, Zió?kowska L, Olivotto I, Khraiche D, Limongelli G, Anastasakis A, Weintraub R, Biagini E, Ragni L, Prendiville T, Duignan S, McLeod K, Ilina M, Fernández A, Marrone C, Bökenkamp R, Baban A, Kubus P, Daubeney PEF, Sarquella-Brugada G, Cesar S, Klaassen S, Ojala TH, Bhole V, Medrano C, Uzun O, Brown E, Gran F, Sinagra G, Castro FJ, Stuart G, Vignati G, Yamazawa H, Barriales-Villa R, Garcia-Guereta L, Adwani S, Linter K, Bharucha T, Garcia-Pavia P, Siles A, Rasmussen TB, Calcagnino M, Jones CB, De Wilde H, Kubo T, Felice T, Popoiu A, Mogensen J, Mathur S, Centeno F, Reinhardt Z, Schouvey S, O'Mahony C, Omar RZ, Elliott PM, Kaski JP.
    • Circ Arrhythm Electrophysiol. 2022 May;15(5):e010075.
  18. Clinical characteristics and frailty status in heart failure with preserved vs. reduced ejection fraction. 
    • Hamada T, Kubo T, Kawai K, Nakaoka Y, Yabe T, Furuno T, Yamada E, Kitaoka H; Kochi YOSACOI study.
    • ESC Heart Fail. 2022 Mar 30.
  19. 99m Technetium-pyrophosphate scintigraphy: a practical guide for early diagnosis of transthyretin amyloid cardiomyopathy.
    • Tahara N, Lairez O, Endo J, Okada A, Ueda M, Ishii T, Kitano Y, Lee HE, Russo E, Kubo T
    • ESC Heart Fail 9; 251-262, 2022.

2021年

  1. Assisted Living and Medication Adherence in Super-Aged Patients With Heart Failure in the Japanese population.
    • Kawada K, Kubo T, Ishida T, Jobu K, Morisawa S, Hamada T, Baba Y, Kawai K, Nakaoka Y, Yabe T, Furuno T, Yamada E, Fukuda H, Ohta T, Hayashi T, Kitaoka H, Miyamura M.
    • J Cardiovasc Pharmacol. 2021 Dec 27.
  2. Association between acute coronary syndrome onset risk and climate change.
    • Aoyagi T, Chiba Y, Kitaoka H.
    • Arch Environ Occup Health. 2021 Dec 15:1-10.
  3. Early cardiac rehabilitation for acute decompensated heart failure safely improves physical function (PEARL study): a randomized controlled trial.
    • Nakaya Y, Akamatsu M, Ogimoto A, Kitaoka H.
    • Eur J Phys Rehabil Med. 2021 Dec;57(6):985-993.
  4. Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy.
    • Kubo T, Baba Y, Ochi Y, Hirota T, Yamasaki N, Kawai K, Yamamoto K, Kondo F, Bando K, Yamada E, Furuno T, Yabe T, Doi YL, Kitaoka H.
    • ESC Heart Fail. 2021 Dec;8(6):5022-5030.
  5. Diagnostic and Therapeutic Strategy for Female Patients With Cardiac Amyloidosis - Reply.
    • Ochi Y, Kubo T, Baba Y, Yamasaki N, Kitaoka H.
    • Circ Rep. 2021 Nov 11;3(12):749-750.
  6. The High Road or the Low Road? A Question Regarding Whether to Use Upper or Lower Pulmonary Veins in Measuring Pulmonary Vein Flow.
    • Baba Y, Kubo T, Kitaoka H.
    • J Am Soc Echocardiogr. 2021 Oct;34(10):1116-1117.
  7. Progressive deterioration of frailty is associated with poor outcomes in patients with transthyretin cardiac amyloidosis.
    • Takahashi M, Okamoto N, Nishida K, Nakaoka Y, Imai RI, Seki SI, Kubo T, Yamasaki N, Kitaoka H, Kubokawa SI, Kawai K, Hamashige N, Doi Y.
    • Geriatr Gerontol Int. 2021 Oct;21(10):967-969.
  8. JCS/JHFS 2018 Guideline on the Diagnosis and Treatment of Cardiomyopathies.
    • Kitaoka H, Tsutsui H, Kubo T, Ide T, Chikamori T, Fukuda K, Fujino N, Higo T, Isobe M, Kamiya C, Kato S, Kihara Y, Kinugawa K, Kinugawa S, Kogaki S, Komuro I, Hagiwara N, Ono M, Maekawa Y, Makita S, Matsui Y, Matsushima S, Sakata Y, Sawa Y, Shimizu W, Teraoka K, Tsuchihashi-Makaya M, Ishibashi-Ueda H, Watanabe M, Yoshimura M, Fukusima A, Hida S, Hikoso S, Imamura T, Ishida H, Kawai M, Kitagawa T, Kohno T, Kurisu S, Nagata Y, Nakamura M, Morita H, Takano H, Shiga T, Takei Y, Yuasa S, Yamamoto T, Watanabe T, Akasaka T, Doi Y, Kimura T, Kitakaze M, Kosuge M, Takayama M, Tomoike H
    • Japanese Circulation Society Joint Working Group.Circ J. 2021 Aug 25;85(9):1590-1689.
  9. Frailty in patients with acute decompensated heart failure in a super-aged regional Japanese cohort.
    • Hamada T, Kubo T, Kawai K, Nakaoka Y, Yabe T, Furuno T, Yamada E, Kitaoka H; Kochi YOSACOI study.
    • ESC Heart Fail. 2021 Aug;8(4):2876-2888.
  10. Wild-Type Transthyretin Amyloidosis in Female Patients - Consideration of Sex Differences.
    • Ochi Y, Kubo T, Baba Y, Sugiura K, Ueda M, Miyagawa K, Noguchi T, Hirota T, Hamada T, Yamasaki N, Kitaoka H.
    • Circ Rep. 2021 Jun 29;3(8):465-471
  11. What is low cardiac output syndrome? A report of two cases
    • Baba Y, Kubo T, Ochi Y, Noguchi T, Yamasaki N, Kitaoka H
    • Crit Care Shock (2021) 24:135-142
  12. Tenosynovial and Cardiac Transthyretin Amyloidosis in Japanese Patients Undergoing Carpal Tunnel Release.
    • Sugiura K, Kozuki H, Ueba H, Kubo T, Ochi Y, Baba Y, Miyagawa K, Noguchi T, Hirota T, Yamasaki N, Wada N, Nakashima J, Murakami I, Ikeuchi M, Kitaoka H.
    • Circ Rep. 2021 May 27;3(6):338-344.
  13. Association between self-reported night sleep duration and cognitive function among older adults with intact global cognition.
    • Kondo R, Miyano I, Lee S, Shimada H, Kitaoka H.
    • Int J Geriatr Psychiatry. 2021 May;36(5):766-774.
  14. A Case Report of Asymmetry of Systolic Anterior Motion of the Mitral Valve, a Not Widely Well-Known but Practically Important Echocardiographic Presentation in Hypertrophic Cardiomyopathy.
    • Ochi Y, Kubo T, Baba Y, Ueda M, Hirota T, Yamasaki N, Kitaoka H.
    • CASE (Phila). 2021 Apr 8;5(3):160-165.
  15. Added value of anxiolytic benzodiazepines in predictive models on severe delirium in patients with acute decompensated heart failure: A retrospective analysis.
    • Kawada K, Fukuda H, Kubo T, Ohta T, Ishida T, Morisawa S, Kawazoe T, Okamoto M, Fujita H, Jobu K, Morita Y, Ueba T, Kitaoka H, Miyamura M.
    • PLoS One. 2021 Apr 22;16(4):e0250372.
  16. A Validation Study of the Mayo Clinic Phenotype-Based Genetic Test Prediction Score for Japanese Patients With Hypertrophic Cardiomyopathy.
    • Moriki T, Kubo T, Sugiura K, Ochi Y, Baba Y, Hirota T, Yamasaki N, Kimura A, Doi YL, Kitaoka H.
    • Circ J. 2021 Apr 23;85(5):669-674.
  17. Validation of the Kumamoto criteria for prediction of 99m technetium pyrophosphate scintigraphy positivity as a strategy for diagnosis of transthyretin cardiac amyloidosis: A retrospective cohort study in Kochi.
    • Ochi Y, Kubo T, Baba Y, Ueda M, Miyagawa K, Noguchi T, Hirota T, Yamasaki N, Kitaoka H
    • J Cardiol 77; 124-130, 2021
  18. What we believed to be a right upper pulmonary vein by transthoracic echocardiography is actually a right lower pulmonary vein.
    • Baba Y, Ochi Y, Hirota T, Arima N, Sugiura K, Kawaguchi J, Hirakawa D, Kubo T, Yamasaki N, Kitaoka H:
    • Echocardiography 38; 427-434, 2021.
  19. The dawn of precision medicine in cardiomyopathies Advance preparations of ethnicity-specific database
    • Kubo T, Morita H
    • Circ J 85; 1479-1480, 2021.
  20. The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy.
    • Norrish G, Topriceanu C, Qu C, Field E, Walsh H, Zió?kowska L, Olivotto I, Passantino S, Favilli S, Anastasakis A, Vlagkouli V, Weintraub R, King I, Biagini E, Ragni L, Prendiville T, Duignan S, McLeod K, Ilina M, Fernández A, Bökenkamp R, Baban A, Drago F, Kubuš P, Daubeney PEF, Chivers S, Sarquella-Brugada G, Cesar S, Marrone C, Medrano C, Alvarez Garcia-Roves R, Uzun O, Gran F, Castro FJ, Gimeno JR, Barriales-Villa R, Rueda F, Adwani S, Searle J, Bharucha T, Siles A, Usano A, Rasmussen TB, Jones CB, Kubo T, Mogensen J, Reinhardt Z, Cervi E, Elliott PM, Omar RZ, Kaski JP
    •  
  21. mTOR-mediated calcium transients affect cardiac function in ex vivo ischemia-reperfusion injury.
    • Shimada BK, Yorichika N, Higa JK, Baba Y, Kobayashi M, Aoyagi T, Suhara T, Matsui T.
    • Physiol Rep. 2021 Mar;9(6):e14807

2020年

  1. Cardiac manifestations and effects of enzyme replacement therapy for over 10 years in adults with the attenuated form of mucopolysaccharidosis type I.
    • Sugiura K, Kubo T, Ochi Y, Baba Y, Hirota T, Yamasaki N, Kitaoka H.

    • Mol Genet Metab Rep. 2020 Oct 20;25:100662.
  2. Elevation of high-sensitivity cardiac troponin T and left ventricular remodelling in hypertrophic cardiomyopathy.
    • Kubo T, Ochi Y, Baba Y, Sugiura K, Takahashi A, Hirota T, Yamanaka S, Yamasaki N, Doi YL, Kitaoka H.
    • ESC Heart Fail. 2020 Oct 12;7(6):3593-600.
  3. The diaphragm affects echocardiographic measurement of inferior vena cava diameter to predict right atrial pressure.
    • Baba Y, Kawaguchi J, Ochi Y, Hirakawa D, Oryu T, Noguchi T, Hirota T, Kubo T, Yamasaki N, Kitaoka H.
    • J Med Ultrason (2001). 2020 Oct;47(4):565-573.
  4. Lifelong Clinical Impact of the Presence of Sarcomere Gene Mutation in Japanese Patients With Hypertrophic Cardiomyopathy.
    • Nakashima Y, Kubo T, Sugiura K, Ochi Y, Takahashi A, Baba Y, Hirota T, Yamasaki N, Kimura A, Doi YL, Kitaoka H.
    • Circ J. 2020 Sep 25;84(10):1846-1853.
  5. Sudden Cardiac Death-Relevant Events of Hypertrophic Cardiomyopathy in a Regional Japanese Cohort - Results From the Kochi RYOMA Study.
    • Kubo T, Baba Y, Ochi Y, Takahashi A, Hirota T, Yamasaki N, Hamashige N, Yamamoto K, Kondo F, Bando K, Yamada E, Furuno T, Yabe T, Doi YL, Kitaoka H.
    • Circ Rep. 2020 Jul 2;2(8):433-439.
  6. Preoperative Clinical Features and High Pulmonary Wedge Pressure with a Discordant Pattern as Prognostic Factor in Hemodialysis Patients with Severe Aortic Valve Stenosis.
    • Ueda M, Kubo T, Ochi Y, Takahashi A, Miyagawa K, Baba Y, Noguchi T, Hirota T, Yamasaki N, Yamamoto M, Nishimori H, Sasaguri S, Orihashi K, Kitaoka H.
    • Int Heart J. 2020 Jul 30;61(4):720-726.
  7. Hypertrophic Cardiomyopathy - A Heterogeneous and Lifelong Disease in the Real World.
    • Kitaoka H, Kubo T, Doi YL.
    • Circ J. 2020 Jul 22;84(8):1218-1226.
  8. Effects of Switching from Treatment with Amlodipine and Atorvastatin Using Two Pills to an Equal Dose of Single-Pill Therapy in Japanese Outpatients.
    • Kawada Y, Kubo T, Baba Y, Hirota T, Tanioka K, Yamasaki N, Kitaoka H.
    • Acta Med Okayama. 2020 Apr;74(2):103-108.
  9. Prediction of Medium-Term Mortality in Japanese Patients With Wild-Type Transthyretin Amyloidosis.
    • Ochi Y, Kubo T, Baba Y, Nakashima Y, Ueda M, Takahashi A, Miyagawa K, Noguchi T, Hirota T, Yamasaki N, Kitaoka H.
    • Circ Rep. 2020 Apr 29;2(6):314-321.
  10. Beneficial Effect of Pimobendan for Severe Heart Failure Due to Transthyretin Cardiac Amyloidosis.
    • Okamoto N, Kubo T, Nakashima Y, Ochi Y, Takahashi A, Baba Y, Hirota T, Yamasaki N, Kitaoka H.
    • Intern Med. 2020 Feb 1;59(3):339-343.
  11. Integrated diagnostic approach to wild-type transthyretin cardiac amyloidosis with the use of high-sensitivity cardiac troponin T measurement and 99mTc-pyrophosphate scintigraphy.
    • Ochi Y, Kubo T, Nakashima Y, Baba Y, Hirota T, Yamasaki N, Yamashita T, Ueda M, Ando Y, Kitaoka H.
    • J Cardiol. 2020 Jan;75(1):12-19.

和文論文

2022年

  1. 心アミロイドーシス患者の心肺運動負荷試験指標の特徴に関する実態調査(原著論文)
    • ?中屋 雄太,大木元 明義, 北岡 裕章
    •  心臓 (0586-4488)54巻1号 Page51-57(2022.01)
  2. 【心筋症診療のフロントライン-概念から最新の治療まで】心筋症の概念(解説/特集)
    • 北岡 裕章
    •  循環器ジャーナル (2432-3284)70巻1号 Page6-12(2022.01)

2021年

  1. 高校生の血圧の経年的な推移~26年間の西土佐地域の学校検診より~
    • 濱川公祐, 矢部敏和, 久保亨, 山崎直仁, 北岡裕章
    • 高知県医師会医医学雑誌 26:137-144, 2021.
  2. 高齢者診療Up To Date 高齢者の心不全診療(解説)
    • 北岡 裕章
    • 新薬と臨牀 (0559-8672)70巻9号 Page1083-1089(2021.09)
  3. 【心筋症1000本ノック!】(ノック1)一次性(原発性)心筋症と二次性心筋症を整理する(解説/特集)
    • 山本 ゆい, 越智 友梨, 北岡 裕章
    • 心エコー (1345-4951)22巻9号 Page810-815(2021.09)
  4. 高齢者心不全と心アミロイドーシス(解説)
    • 北岡 裕章
    • 老年内科 (2435-1881)4巻1号 Page57-65(2021.07)
  5. Eclipsed mitral regurgitationが疑われた僧帽弁逆流の1例
    • 岡本都, 越智友梨, 久保亨, 杉浦健太, 宮川和也, 馬場裕一, 野口達哉, 弘田隆省, 濱田知幸, 山崎直仁, 北岡裕章 
    • 心臓 53巻4号 Page386-392(2021.04)

症例報告

2023年

  1. Where Is the Left Atrial Appendage Wall? Caution during Transesophageal Echocardiography.  
    • Baba Y, Ochi Y, Kawaguchi J, Takiishi A, Hirota T, Kubo T, Yamasaki N, Kitaoka H.
    • CASE (Phila). 2023 Jun 12;7(8):338-342.doi: 10.1016/j.case.2023.04.008. eCollection 2023 Aug.
  2. Left Atrial Appendage Closure with the Watchman FLX System in a Patient with Hypertrophic Cardiomyopathy on Dialysis for End-stage Renal Failure  
    • Takashi Funaki, Mike Saji, Mai Terada, Itaru Takamisawa, Mamoru Nanasato, Takehiko Nagao, Takanori Ikeda, Mitsuaki Isobe.
    • Intern Med. 2024 Feb 1;63(3):399-402. DOI: 10.2169/internalmedicine.1778-23

2021年

  1. A case reprt of asymmetry of systolic anterior motion of the mitral vlave, a not widely well-known but practically iportant echocardiographoic presentaton in hypertrophic cardiomyopathy. 
    • Ochi Y, Kubo T, Baba Y, Ueda M, Hirota T, Yamasaki N, Kitaoka H.
    • CASE (Phila) 5: 160-165, 2021. (IF 5.251)

学会発表

2024年

  1. Insights into atrial fibrillation and atrial function in patients with cardiac hypertrophy.
    • 久保亨
    • 第88回日本循環器学会学術集会
  2. Fabry disease and its cardiac involvement
    • 久保亨
    • 第88回日本循環器学会学術集会
  3. ?Modes of Death in Patients with Heart Failure according to Walking Ability and Left Ventricular Ejection Fraction?   
    • Hamada T, Kubo T, Kawai K,  Nakaoka Y,  Yabe T,  Furuno T, Yamada E, Kawada Y, Yamasaki N, Takabayashi K, Kitaoka H
    • 第88回日本循環器学会学術集会
  4. 4D strainにて “真” のストレインにせまる -2D strainは虚像か?-  
    • 馬場裕一
    • 第35回日本心エコー図学会
  5. 四国の絆を心エコー図で結ぶ ~『高知家』の取り組み~
    • 馬場裕一
    • 第35回日本心エコー図学会
  6. Prospective multi-center screening with high-sensitivity cardiac troponin T measurement for wild-type transthyretin cardiac amyloidosis  in outpatient and community-based settings
    • Naoki Arima, Yuri Ochi, Toru Kubo, Yuichi Baba, Naohito Yamasaki, Hiroaki Kitaoka
    • 第88回日本循環器学会学術集会
  7. 部分肺静脈環流異常症の血流分配を含めた血行動態評価及び管理について
    • 石井奈津子,越智友梨,馬場裕一,山崎直仁,前田美咲,玉城渉,山本雅樹,藤枝幹也,久保亨,北岡裕章
    • 第25回日本成人先天性心疾患学会 総会?学術集会
  8. 低心拍出を伴う急性心不全の薬物治療:強心薬と血管拡張薬の“さじ加減” ドパミン
    • 石井奈津子
    • 第88回日本循環器学会学術集会
  9. Clinical importance of native T1 mapping in screening on MRI of Cardiac Fabry disease     
    • 舟木孝志
    • 第88回日本循環器学会学術集会
  10. Impact of Osteoporotic Risk in Patients Undergoing Transcatheter Aortic Valve Replacement: A Report from the LAPLACE-TAVI Registry
    • 舟木孝志
    • 第88回日本循環器学会学術集会  
  11. 高度低ナトリウム血症による意識障害を呈し超高齢男性の1例   
    • OMATI OTAVIO
    • 第35回日本老年医学会四国地方会  
  12. A Patient with Heterozygous Familial Hypercholesterolemia Who Developed Very Severe Aortic Stenosis and Coronary Artery Disease in his 50’s
    • 吉本公美
    • 第88回日本循環器学会学術集会

2023年

  1. 本邦における肥大型心筋症の遺伝学的検査の展望
    • 久保亨
    • 日本心臓病学会第71回学術集会
  2. 循環器診療における心アミロイドーシスの診断と治療    
    • 久保亨
    • 第10回日本アミロイドーシス学会学術集会
  3. 高齢急性心不全患者における簡易版高齢者総合機能評価(CGA7)と退院後予後との関連
    • 濱田知幸, 久保 亨, 中岡洋子, 川井和哉, 矢部敏和, 山田英介, 古野貴志, 北岡裕章
    • 第65回日本老年医学会学術集会
  4. The prognostic impact of cardio-renal anaemia syndrome in Japanese acute decompensated heart failure patients stratified by left ventricular ejection fraction
    • Moriki T, Hamada T, Kubo T, Takabayashi K, Kawai K, Nakaoka Y, Yabe T, Furuno T, Yamada E, Kitaoka H
    • European Society of Cardiology Congress, Amsterdam, 2023
  5. 急性心不全患者における基本チェックリストで評価した社会的脆弱性の予後への影響
    • 濵田 知幸, 久保 亨, 中岡 洋子, 川井 和哉, 矢部敏和, 桑原 昌則, 古野 貴志, 川田 泰正, 山田 英介, 山﨑直仁, 北岡 裕章
    • 第27回日本心不全学会学術集 
  6. Predicting New Diagnoses of Cardiac Sarcoidosis during Follow-up Periods in Patients with Systemic Sarcoidosis
    • 馬場裕一
    • 第87回日本循環器学会学術集会
  7. 全身性サルコイドーシスにおける新規心病変合併の検討
    • 馬場裕一
    • 第71回日本心臓病学会学術集会
  8. 生活習慣は野生型トランスサイレチン心アミロイドーシスの 予後に影響を与えるかもしれない
    • 馬場裕一
    • 第27回日本心不全学会学術集会
  9. 後期高齢者PCI患者の脂質管理状況とリスクファクターの考察
    • 宮川和也,宮本雄也,森木俊宏,古島知樹,野口達哉,濵田知幸,久保亨,山崎直仁,北岡裕章
    • 第65回日本老年医学会学術集会
  10. 稀な原因で心臓外科術後に合併した周術期心筋梗塞の2症例
    • 宮川和也,岡本都,濵田幸汰,西村拓哉,古島知樹,森木俊宏,野口達哉,北岡裕章
    • 第29回日本心血管インターベンション治療学会 中国四国地方会
  11. 低容量血栓溶解療法が有効であった人工弁機能不全の一例
    • 古島知樹
    • 第71回日本心臓病学会学術集会
  12. A LIMITED PATHOGENIC ACTIVITY OF CTLS ALONE THAT ARE SPECIFIC FOR CARDIAC MYOSIN HEAVY CHAIN-ALPHA IN AN EXPERIMENTAL AUTOIMMUNE MYOCARDITIS
    • Arima N, Kitaoka H, Udaka K
    • ACC.23 Annual Scientific Session & Expo Together With World Congress of Cardiology
  13. A DYNAMIC ECG CHANGE IN PATIENT WITH ACUTE ANTERIOR MYOCARDIAL INFARCTION - A NAME HAS CHANGED FROM DE WINTER TO WELLENS
    • Arima N, Yamasaki N, Furushima T, Miyamoto Y, Moriki T, Miyagawa K, Noguchi T, Kubo T, Kitaoka H
    • ACC.23 Annual Scientific Session & Expo Together With World Congress of Cardiology 
  14. 高齢者における野生型トランスサイレチン心アミロイドーシス有病率の推定 一般内科外来における高感度心筋トロポニンT測定による調査
    • 有馬直輝,越智友梨,久保亨,村上義典,西野潔,山本博憲,佐藤幸治,田村親史郎,大川真理,髙田浩史,清水祐司,馬場裕一,山崎直仁,北岡裕章
    • 第10回日本アミロイドーシス学会
  15. 心臓MRIによる修正大血管転位術後の左心房機能評価:解剖学的修復のpitfall
    • 石井奈津子,大内秀雄,森有希,森田佳明,黒嵜健一
    • 第6回小児心臓MR研究会  
  16. 3面相の心筋障害を呈した症例
    • 石井奈津子
    • 第9回心筋症研究会
  17. 肺動脈楔入圧とIII音の関係に関する検討
    • 石井奈津子,馬場裕一,山崎直仁,久保亨,北岡裕章
    • 第27回日本心不全学会学術集会
  18. この心不全患者の貧血、補正すべき?
    • 石井奈津子
    • 第27回日本心不全学会学術集会
  19. 免疫抑制剤使用中に骨盤直腸窩膿瘍を生じた心臓移植後患者の 1 例
    • 石井奈津子
    • 第78回日本大腸肛門病学会学術集会
  20. 炎症細胞浸潤をともなったLMNA関連心筋症の一例
    • 石井奈津子,久保亨,北岡裕章,渡邉琢也,塚本泰正,雨宮妃,松本学,大郷恵子,池田善彦,畠山金太
    • 第45回心筋生検研究会学術集会
  21. 免疫チェックポイント阻害薬関連心筋炎の重症度評価における心臓MRの重要性
    • 石井奈津子
    • 第123回日本循環器学会 四国地方会
  22. Coronary ostial patch-angioplasty, a novel surgical technique using an external iliac artery for 3 young female patients with Takayasu arteritis
    • 舟木孝志
    • 第87回 日本循環器学会学術集会
  23. Mid-term outcome after transcatheter aortic valve replacement in patients with dementia: an insight from the LAPLACE-TAVI registry
    • 舟木孝志
    • 第87回 日本循環器学会学術集会
  24. Left atrial appendage closure with the Watchman FLX system in a patient with hypertrophic cardiomyopathy on dialysis for end-stage renal failure
    • 舟木孝志
    • PCR Tokyo Valves 2023
  25. 血管内視鏡にて左心耳閉鎖デバイスの内皮化を評価した1例
    • 舟木孝志
    • 第16回TRANS CATHETER IMAGING FORUM
  26. Intra-annular SEV か?pop-outした1例: 至適な深さはと?こにあるか
    • 舟木孝志
    • ストラクチャークラブ?ジャパン ライブデモンストレーション 2023
  27. 10年後のストラクチャーインターベンションを話そう
    • 舟木孝志
    • ストラクチャークラブ?ジャパン ライブデモンストレーション 2023
  28. 若手インタラクティブセッション:新時代はこの未来だーガイドライン改定は現場をどう変えたか?—
    • 舟木孝志
    • 第31回日本心血管インターベンション治療学会学術集会
  29. 短腸症候群に対するテデュグルチド治療により心不全発症をきたした1例
    • 吉本公美
    • 第123回日本循環器学会四国地方会

2022年

  1. 超高齢者(oldest-old)入院患者における リスクスコアを加味した抗血栓療法の考察
    • 宮川和也
    • 第64回日本老年医学会学術集会 
  2. Prevalence and clinical impact of cardiorenal anemia syndrome in older patients with acute heart failure.
    • 濵田知幸
    • 第26回日本心不全学会学術集会 
  3. 高齢急性心不全患者におけるフレイル重積の退院1年以内の予後への影響
    • 濵田知幸
    • 第64回日本老年医学会学術集会
  4. Prognostic Impact of Frailty Status Based on the Kihon Checklist in Patients With Acute Decompensated Heart Failure
    • 濵田知幸
    • 第86回日本循環器学会学術集会
  5. Additional Prognostic Value of Frailty Assessment to the Get With the Guideline-Heart Failure Risk Score in Patients With Acute Decompensated Heart Failure
    • 濵田知幸
    • 第86回日本循環器学会学術集会
  6. Hydrophilic polymer emboli in patients with critical limb ischemia: a review of four cases leading to critical outcomes
    • 宮本雄也
    • 第30回日本心血管インターベンション治療学会
  7. What are the Characteristics of Lesions with Target Lesion Failure at Follow-up Coronary Angiography after Percutaneous Coronary Intervention?
    • 宮本雄也
    • 第30回日本心血管インターベンション治療学会
  8. 右冠動脈のカテーテル治療中に著明な冠動脈-大動脈解離を来したが、ステント留置で偽腔退縮に成功した1例
    • 宮本雄也,野口達哉,森木俊宏,古島知樹,宮川和也,久保亨,山崎直仁,北岡裕章
    • 第126回日本内科学会四国地方会
  9. ミトコンドリア心筋症の遺伝学的検査における限界と尿検体解析への期待
    • 本田哲彬,和泉伸之輔,久保亨,杉浦健太,山崎直仁,北岡 裕章
    • 第120回日本循環器学会中国?四国合同地方会
  10. 十二指腸内視鏡検査にて診断に至った、腹部人工血管感染を伴う大動脈十二指腸瘻の一例
    • 高村洸輝,宮本雄也,森木俊宏,古島知樹,宮川和也,野口達哉,久保亨,山崎直仁,三石淳之,北川博之,花崎和弘,三浦友二郎,北岡裕章
    • 第120回日本循環器学会中国?四国合同地方会
  11. 心筋ミオシン重鎖特異的細胞傷害性 T 細胞による自己免疫性心筋炎の誘導
    • 有馬直輝,北岡裕章,宇高恵子
    • 第120回日本循環器学会中国?四国合同地方会
  12. 日本人地域集団における肥大型心筋症患者の心不全の特徴ーKochi RYOMA Studyー
    • 宮本雄也,越智友梨,宮川和也,馬場裕一,野口達哉?弘田隆省,濵田知幸,久保亨,山崎直仁,北岡裕幸
    • 第8回日本心筋症研究会
  13. 閉塞性肥大型心筋症に対する薬物療法の現状と今後の展望
    • 杉浦健太,久保亨,山崎直仁,北岡裕章
    • 第8回日本心筋症研究会
  14. 我が国における肥大型心筋症のマネジメント
    • 久保亨,山崎直仁,北岡裕章
    • 第8回日本心筋症研究会

2021年

  1. Drug treatment for obstructive hypertrophic cardiomyopathy
    • 久保亨, 杉浦健太. 山崎直仁,北岡裕章
    • 第86回日本循環器学会学術集会
  2. Prognostic Impact of Frailty Status Based on the Kihon Checklist in Patients With Acute Decompensated Heart Failure
    • 濵田知幸,久保亨,中岡洋子,川井和哉,矢部敏和,桑原昌則,古野貴志,山田英介,山崎直仁,北岡裕章
    • 第86回日本循環器学会学術集会
  3. Additional Prognostic Value of Frailty Assessment to the Get With the Guideline-Heart Failure Risk Score in Patients With Acute Decompensated Heart Failure
    • 濵田知幸,久保亨,中岡洋子,川井和哉,矢部敏和,桑原昌則,古野貴志,山田英介,山崎直仁,北岡裕章
    • 第86回日本循環器学会学術集会
  4. Induction of Autoimmune Myocarditis by CTLs Specific for Cardiac Myosin Heavy Chain-Alpha
    • 有馬直樹, 北岡裕章, 宇高恵子
    • 第86回日本循環器学会学術集会
  5. 当院における高齢心房細動患者に対するカテーテルアブレーション治療の有効性?安全性に関する検討
    • 有馬 直輝, 弘田 隆省, 宮川 和也, 馬場 裕一, 野口 達哉, 濵田 知幸, 久保 亨, 山崎 直仁, 北岡 裕章
    • 第33回日本老年医学会四国地方会
  6. 抗NMDA受容体脳炎による洞停止のため、一時的ペースメーカを要した症例
    • 有馬 直輝, 馬場 裕一, 杉浦 健太, 宮川 和也, 野口 達哉, 弘田 隆省, 濵田 知幸, 久保 亨, 山崎 直仁, 北岡 裕章
    • 第119回日本循環器学会四国地方会
  7. Prognostic Impact of Early Readmission for Heart Failure and Frailty Status in Patients with Acute Heart Failure
    • 濵田知幸,久保亨,中岡洋子,川井和哉,矢部敏和,古野貴志,山田英介,山崎直仁,北岡裕章
    • 第25回日本心不全学会学術集会
  8. Is verapamil really contraindication for rate control of atrial fibrillation in patients with heart failure?
    • Yuichi Baba, Toru Kubo, Kei Kawada, Yuri Ochi, Takayoshi Hirota, Naohito Yamasaki, Hiroaki Kitaoka
    • 第25回日本心不全学会学術集会
  9. 左心耳の壁はどこ?
    • 馬場裕一,  越智友梨, 川口樹里, 瀧石亜純, 上田素子, 弘田隆省, 久保亨, 山崎直仁, 北岡裕章
    • 日本超音波医学会第31回四国地方会
  10. ここがヘンだよガイドライン「心不全合併の頻脈性心房細動に対する非ジヒドロピリジン系カルシウム拮抗薬はClass III ではない」
    • 馬場裕一
    • 第69 回日本心臓病学会学術集会
  11. 重症下肢虚血へのEVT後に親水性ポリマーによる微小血管塞栓を来した一例
    • 宮本雄也,野口達哉,森木俊宏,古島知樹,宮川和也,馬場裕一,弘田隆省,濵田知幸,久保亨,山崎直仁,北岡裕章
    • 第69回日本心臓病学会学術集会
  12. 高齢急性非代償性心不全患者における退院時歩行能力の臨床アウトカムへの影響
    • 濵田知幸,久保 亨,川井和哉,矢部敏和,山田英介,古野貴志.北岡裕章 
    • 第63回日本老年医学会学術集会
  13. 高知急性非代償性心不全レジストリ研究から見えてくる心不全患者マネジメントの課題と高知県の取り組み
    • 久保亨, 濵田知幸, 山崎直仁, 北岡裕章
    • 第63回日本老年医学会学術集会
  14. 心エコー図による心アミロイドーシスの見つけ方
    • 久保亨, 越智友梨, 北岡裕章
    • 日本心エコー図学会第32回学術集会